Access to quality diagnostics is one of the strongest predictors of better healthcare outcomes. Yet for thousands of laboratories across emerging markets, cost continues to stand in the way of that access.
One of India's fastest-growing in-vitro diagnostics companies set out to change that equation. Their ambition was clear: build a fully automatic hematology analyzer that could match the performance of premium global systems while remaining affordable enough to serve the labs that need it most.
LTTS partnered with them to engineer the platform end to end. By bringing together microfluidics, analog electronics, embedded systems, and medical device engineering, we built a diagnostic solution designed for what truly matters in emerging markets: precision, affordability, and scale.
Why It Matters
Diagnostics is the foundation of every healthcare decision. When cost goes down and access goes up, outcomes improve across entire healthcare systems. This solution is proof of what becomes possible when engineering meets purpose. It shows how Engineering Intelligence can close the gap between accessibility and technological excellence, enabling broader diagnostic coverage without compromising on precision, quality, or regulatory rigor.
Download the case study to explore how precision engineering is scaling accessibility across global healthcare.